HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang Ke Selected Research

6-chloropenicillanic acid S-sulfoxide

12/2021The Incidence of Lymphoma in Beijing: Comparing Results from MIS-CASS (2019) and Beijing Cancer Registry (2017).
3/2021Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in China.
3/2020Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang Ke Research Topics

Disease

52Neoplasms (Cancer)
01/2022 - 02/2002
16Hepatocellular Carcinoma (Hepatoma)
03/2022 - 02/2004
14Esophageal Squamous Cell Carcinoma
12/2022 - 06/2003
9Carcinoma (Carcinomatosis)
01/2017 - 12/2002
8Esophageal Neoplasms (Esophageal Cancer)
04/2021 - 10/2002
8Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2021 - 03/2015
7Neoplasm Metastasis (Metastasis)
12/2021 - 02/2002
7Stomach Neoplasms (Stomach Cancer)
03/2017 - 05/2003
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2013 - 10/2005
5Infections
01/2021 - 08/2004
5Carcinogenesis
01/2017 - 08/2003
4Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2019 - 08/2004
4Liver Neoplasms (Liver Cancer)
01/2019 - 09/2013
3Obesity
04/2018 - 01/2017
3Papillomavirus Infections
11/2015 - 07/2005
3Breast Neoplasms (Breast Cancer)
07/2015 - 02/2002
2Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 08/2015
2Lymphoma (Lymphomas)
12/2021 - 04/2011
2Dyslipidemias (Dyslipidemia)
11/2021 - 06/2020
2Inflammation (Inflammations)
01/2021 - 05/2020
2Lymphatic Metastasis
10/2020 - 01/2014
2Pain (Aches)
05/2020 - 10/2017
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 11/2003
2Hypertension (High Blood Pressure)
05/2018 - 11/2013
2Uterine Cervical Dysplasia
01/2017 - 10/2016
2Colorectal Neoplasms (Colorectal Cancer)
03/2015 - 11/2013
2Adenocarcinoma
03/2015 - 11/2003
2Diabetes Mellitus
08/2014 - 01/2014
2Lung Neoplasms (Lung Cancer)
04/2006 - 12/2005
1Malnutrition (Nutritional Deficiencies)
11/2021
1Thrombocytopenia (Thrombopenia)
02/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2021
1Essential Thrombocythemia
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Primary Myelofibrosis (Myelosclerosis)
01/2021

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2003
9DNA (Deoxyribonucleic Acid)IBA
01/2017 - 02/2002
8Messenger RNA (mRNA)IBA
01/2021 - 06/2003
7Codon (Codons)IBA
01/2012 - 10/2002
6Inosine Triphosphate (ITP)IBA
02/2021 - 03/2015
5Biological ProductsIBA
01/2019 - 08/2003
5MicroRNAs (MicroRNA)IBA
01/2019 - 01/2013
4CholesterolIBA
11/2021 - 01/2017
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
36-chloropenicillanic acid S-sulfoxideIBA
12/2021 - 03/2020
3LDL CholesterolIBA
11/2021 - 06/2020
3Triglycerides (Triacylglycerol)IBA
11/2021 - 06/2020
3HDL CholesterolIBA
11/2021 - 06/2020
3oxidized low density lipoproteinIBA
11/2021 - 06/2020
3Oncogene Proteins (Oncogene Protein)IBA
11/2015 - 06/2003
2Competitive Endogenous RNAIBA
03/2022 - 01/2019
2IodineIBA
01/2022 - 01/2020
2Butylated Hydroxyanisole (BHA)IBA
11/2021 - 06/2020
2CytokinesIBA
02/2021 - 01/2021
2AntigensIBA
10/2020 - 01/2019
2BilirubinIBA
05/2020 - 03/2014
2Long Noncoding RNAIBA
01/2020 - 01/2019
2Coloring Agents (Dyes)IBA
01/2020 - 10/2018
2GoldIBA
12/2019 - 12/2019
2Pharmaceutical PreparationsIBA
12/2019 - 01/2018
2Dexamethasone (Maxidex)FDA LinkGeneric
08/2019 - 01/2018
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2019 - 02/2006
2Sorafenib (BAY 43-9006)FDA Link
05/2018 - 01/2017
2Histidine (L-Histidine)FDA Link
01/2018 - 03/2016
2NucleotidesIBA
01/2018 - 03/2016
2Carrier Proteins (Binding Protein)IBA
01/2018 - 03/2016
2Small Interfering RNA (siRNA)IBA
11/2016 - 07/2015
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
03/2016 - 11/2015
2Antiviral Agents (Antivirals)IBA
08/2015 - 09/2013
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2014 - 03/2014
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2013 - 02/2006
2Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
03/2011 - 08/2004
2Genetic Markers (Genetic Marker)IBA
05/2003 - 05/2003
1Fibrinogen (Factor I)FDA Link
09/2022
1AlbuminsIBA
09/2022
1Hypoxia-Inducible Factor 1IBA
01/2022
1Aldehyde Reductase (Aldose Reductase)IBA
12/2021
1fidarestatIBA
12/2021
1AutoantibodiesIBA
11/2021
1Biocompatible Materials (Biomaterials)IBA
10/2021
1MicellesIBA
10/2021
1Polysaccharides (Glycans)IBA
10/2021
1Chloroquine (Aralen)FDA LinkGeneric
10/2021
1Hemoglobins (Hemoglobin)IBA
06/2021
1LipidsIBA
04/2021
1InterleukinsIBA
02/2021
1Interleukin-1 (Interleukin 1)IBA
02/2021
1Fetal Proteins (Fetoprotein)IBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
01/2021
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2021
1Chemokine CCL24IBA
01/2021
1CarbohydratesIBA
10/2020

Therapy/Procedure

12Therapeutics
12/2022 - 09/2013
4Esophagectomy
12/2022 - 06/2021
3Radiotherapy
03/2019 - 12/2011
3Hepatectomy
08/2015 - 09/2013
2Immunotherapy
10/2021 - 01/2017
2Drug Therapy (Chemotherapy)
05/2020 - 11/2013
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2013 - 12/2011